[Clinical study to evaluate EPA-enriched immunonutrition with ProSureTM during chemotherapy in cancer patients].
We report a prospective, single-arm, pilot study conducted by the Tokyo Metropolitan Oncology Group in order to evaluate the effect of a fish-oil enriched nutritional supplement(ProSureTM) during cancer chemotherapy in patients with advanced cancer. ProSureTM was given for more than 1 month to patients with advanced cancer whose prognosis was more than 3 months before enrollment. Laboratory data including serum albumin level, body weight, body composition, and functional status data were collected at baseline, 14 days, and 28 days. Oral supplementation consisted of 2 packs of ProSureTM per day for more than 28 days during chemotherapy. The study population included 50 patients. This study is now ongoing.